| 注册
首页|期刊导航|中国药理学通报|桑皮苷的药理作用研究进展

桑皮苷的药理作用研究进展

黎玉华 温金华 周健 钟国平 黄民 毕惠嫦 魏筱华

中国药理学通报2018,Vol.34Issue(6):749-752,4.
中国药理学通报2018,Vol.34Issue(6):749-752,4.DOI:10.3969/j.issn.1001-1978.2018.06.003

桑皮苷的药理作用研究进展

Research progress of pharmacological effects of mulberroside

黎玉华 1温金华 1周健 1钟国平 2黄民 2毕惠嫦 2魏筱华1

作者信息

  • 1. 南昌大学第一附属医院药学部,江西 南昌 330006
  • 2. 中山大学药学院,广东 广州 510006
  • 折叠

摘要

Abstract

Mulberroside, a glycosylated stilbene, is the main bioactive constituent of white mulberry root-bark ( Sangbaipi) . It is widely used in many famous traditional Chinese medicine pre-scriptions to treat gout, arthritis, and rheumatism through pur-ging diuresis and relieving edema. In recent years, the pharma-cological activity of mulberroside has drawn extensive attention. With the utilization of the techniques and methods of modern pharmacology, a variety of biological activity and pharmacologi-cal effects of mulberroside are discovered gradually. The recent progress in the research on pharmacological effects of mulberro-side was reviewed in this paper to provide reference for the fur-ther development and comprehensive utilization.

关键词

桑皮苷/消炎镇痛/抗氧化/降血脂/药理作用/研究进展

Key words

mulberroside/anti-inflammation/anti-oxidation/hypolipidemic/pharmacological effects/research progress

分类

医药卫生

引用本文复制引用

黎玉华,温金华,周健,钟国平,黄民,毕惠嫦,魏筱华..桑皮苷的药理作用研究进展[J].中国药理学通报,2018,34(6):749-752,4.

基金项目

国家自然科学基金资助项目(No 81660618) (No 81660618)

中国药理学通报

OA北大核心CSCDCSTPCD

1001-1978

访问量3
|
下载量0
段落导航相关论文